<?xml version="1.0" encoding="UTF-8"?>
<ListRecords>
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:title>Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task</dc:title>
  <dc:creator>STEPHAN, K. E</dc:creator>
  <dc:creator>MAGNOTTA, V. A</dc:creator>
  <dc:creator>WHITE, T</dc:creator>
  <dc:creator>ARNDT, S</dc:creator>
  <dc:creator>FLAUM, M</dc:creator>
  <dc:creator>O'LEARY, D. S</dc:creator>
  <dc:creator>ANDREASEN, N. C</dc:creator>
  <dc:relation>Psychological medicine (Print) -- Psychol. med. (Print), CODEN PSMDCO, ISSN 0033-2917, Vol. 31 (6) , pp. 1065-1078</dc:relation>
  <dc:date>2001</dc:date>
  <dc:type>Text</dc:type>
  <dc:type>Article</dc:type>
  <dc:language>English</dc:language>
  <dc:publisher>Cambridge University Press</dc:publisher>
  <dc:format>print</dc:format>
  <dc:format>1 p.3/4</dc:format>
  <dc:subject xml:lang="fr">Imagerie médicale</dc:subject>
  <dc:subject xml:lang="fr">Psychose</dc:subject>
  <dc:subject xml:lang="fr">Antagoniste dopamine</dc:subject>
  <dc:subject xml:lang="fr">Antagoniste sérotonine</dc:subject>
  <dc:subject xml:lang="fr">Cervelet</dc:subject>
  <dc:subject xml:lang="fr">Chimiothérapie</dc:subject>
  <dc:subject xml:lang="fr">Cognition</dc:subject>
  <dc:subject xml:lang="fr">Cortex cérébral</dc:subject>
  <dc:subject xml:lang="fr">Encéphale</dc:subject>
  <dc:subject xml:lang="fr">Etude comparative</dc:subject>
  <dc:subject xml:lang="fr">Etude expérimentale</dc:subject>
  <dc:subject xml:lang="fr">Homme</dc:subject>
  <dc:subject xml:lang="fr">Imagerie RMN</dc:subject>
  <dc:subject xml:lang="fr">Latéralité</dc:subject>
  <dc:subject xml:lang="fr">Mécanisme action</dc:subject>
  <dc:subject xml:lang="fr">Neuroleptique</dc:subject>
  <dc:subject xml:lang="fr">Olanzapine</dc:subject>
  <dc:subject xml:lang="fr">Psychotrope</dc:subject>
  <dc:subject xml:lang="fr">Réseau nerveux</dc:subject>
  <dc:subject xml:lang="fr">Schizophrénie</dc:subject>
  <dc:subject xml:lang="fr">Spécialisation hémisphérique</dc:subject>
  <dc:subject xml:lang="fr">Système nerveux central</dc:subject>
  <dc:subject xml:lang="fr">Thalamus</dc:subject>
  <dc:subject xml:lang="fr">Traitement</dc:subject>
  <dc:subject xml:lang="fr">Imagerie fonctionnelle</dc:subject>
  <dc:subject xml:lang="fr">Thiéno benzodiazépine dérivé</dc:subject>
  <dc:subject xml:lang="en">Medical imagery</dc:subject>
  <dc:subject xml:lang="en">Psychosis</dc:subject>
  <dc:subject xml:lang="en">Dopamine antagonist</dc:subject>
  <dc:subject xml:lang="en">Serotonin antagonist</dc:subject>
  <dc:subject xml:lang="en">Cerebellum</dc:subject>
  <dc:subject xml:lang="en">Chemotherapy</dc:subject>
  <dc:subject xml:lang="en">Cognition</dc:subject>
  <dc:subject xml:lang="en">Cerebral cortex</dc:subject>
  <dc:subject xml:lang="en">Brain (vertebrata)</dc:subject>
  <dc:subject xml:lang="en">Comparative study</dc:subject>
  <dc:subject xml:lang="en">Experimental study</dc:subject>
  <dc:subject xml:lang="en">Human</dc:subject>
  <dc:subject xml:lang="en">Nuclear magnetic resonance imaging</dc:subject>
  <dc:subject xml:lang="en">Laterality</dc:subject>
  <dc:subject xml:lang="en">Mechanism of action</dc:subject>
  <dc:subject xml:lang="en">Neuroleptic</dc:subject>
  <dc:subject xml:lang="en">Olanzapine</dc:subject>
  <dc:subject xml:lang="en">Psychotropic</dc:subject>
  <dc:subject xml:lang="en">Nervous network</dc:subject>
  <dc:subject xml:lang="en">Schizophrenia</dc:subject>
  <dc:subject xml:lang="en">Hemispheric specialization</dc:subject>
  <dc:subject xml:lang="en">Central nervous system</dc:subject>
  <dc:subject xml:lang="en">Thalamus</dc:subject>
  <dc:subject xml:lang="en">Treatment</dc:subject>
  <dc:subject xml:lang="en">Functional imaging</dc:subject>
  <dc:subject xml:lang="es">Imageneria medical</dc:subject>
  <dc:subject xml:lang="es">Psicosis</dc:subject>
  <dc:subject xml:lang="es">Antagonista dopamina</dc:subject>
  <dc:subject xml:lang="es">Antagonista serotonina</dc:subject>
  <dc:subject xml:lang="es">Cerebelo</dc:subject>
  <dc:subject xml:lang="es">Quimioterapia</dc:subject>
  <dc:subject xml:lang="es">Cognición</dc:subject>
  <dc:subject xml:lang="es">Corteza cerebral</dc:subject>
  <dc:subject xml:lang="es">Encéfalo</dc:subject>
  <dc:subject xml:lang="es">Estudio comparativo</dc:subject>
  <dc:subject xml:lang="es">Estudio experimental</dc:subject>
  <dc:subject xml:lang="es">Hombre</dc:subject>
  <dc:subject xml:lang="es">Imageria RMN</dc:subject>
  <dc:subject xml:lang="es">Lateralidad</dc:subject>
  <dc:subject xml:lang="es">Mecanismo acción</dc:subject>
  <dc:subject xml:lang="es">Neuroléptico</dc:subject>
  <dc:subject xml:lang="es">Olanzapina</dc:subject>
  <dc:subject xml:lang="es">Psicotropo</dc:subject>
  <dc:subject xml:lang="es">Red nerviosa</dc:subject>
  <dc:subject xml:lang="es">Esquizofrenia</dc:subject>
  <dc:subject xml:lang="es">Especialización hemisférica</dc:subject>
  <dc:subject xml:lang="es">Sistema nervioso central</dc:subject>
  <dc:subject xml:lang="es">Tálamo</dc:subject>
  <dc:subject xml:lang="es">Tratamiento</dc:subject>
  <dc:subject>002B02B03: Psycholeptiques: tranquillisant, neuroleptique. / Psycholeptics: tranquillizer, neuroleptic.</dc:subject>
  <dc:subject>770-: Psychologie. Psychanalyse. Psychiatrie / Psychology. Psychoanalysis. Psychiatry</dc:subject>
  <dc:subject>770-E: Psychopharmacologie / Psychopharmacology</dc:subject>
  <dc:rights>Inist-CNRS</dc:rights>
  <dc:identifier>Inist-CNRS record number 1071256</dc:identifier>
  <dc:rights>Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS</dc:rights>
</metadata>
</ListRecords>